
Quiz|Articles|March 1, 2024
Rx Roundup: Quiz of the Week
Test your pharmacy news knowledge with our weekly quiz: February 26 to March 1
Advertisement
Did you get your fill of pharmacy news this week? Take the Rx Roundup quiz of the week and test your knowledge about the latest stories published by the Drug Topics team from February 26 to March 1.
Question 1
Abrysvo is FDA approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older. What is the durable efficacy of Abrysvo against lower respiratory tract disease with 3 or more symptoms after 2 full RSV seasons?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























